{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T15:14:04Z","timestamp":1784646844851,"version":"3.55.0"},"reference-count":0,"publisher":"Journal of Biological Methods","issue":"2","license":[{"start":{"date-parts":[[2020,10,5]],"date-time":"2020-10-05T00:00:00Z","timestamp":1601856000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HPR"],"abstract":"<jats:p>This review focuses on smoking cessation treatments for peo ple with schizophrenia spectrum disorders. It concludes with com ments on the significance of the research and why it constitutes an original contribution. We searched PubMed (National Library of Medicine), and PsycINFO (Ovid) (2006-2020) for studies on schizophrenic disorder (schizophrenia or psychotic or psychosis or severe mental illness) and smoking cessation treatment (smok ing cessation treatment or varenicline or tobacco cessation or reduction or bupropion or NRT or behavioral treatment or e-ciga rette). Studies found evidence suggesting that pharmacotherapy combined with behavioural therapy for smoking cessation is effective amongst smokers with schizophrenia spectrum disorders, although more long-term research is required. This review sum marised and critically reviewed also studies on vaping as a smok ing cessation strategy for smokers with schizophrenia spectrum disorders and evidence suggests that they may effective as smok ing cessation tool and may be less harmful alternatives to com bustible cigarette smoking. Consequently, e-cigarettes could be considered as an applicable instrument for Tobacco Harm Reduction (THR) and smoking cessation. Overall, there are very few studies of e-cigarettes for smoking cessation in patients with schizophrenia and these studies are very small. They have promis ing results, but more research is needed.&amp;nbsp;<\/jats:p>","DOI":"10.4081\/hpr.2020.9237","type":"journal-article","created":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T07:50:26Z","timestamp":1602575426000},"page":"1","source":"Crossref","is-referenced-by-count":7,"title":["Approved and emerging smoking cessation treatments for people \u00a0with schizophrenia spectrum disorders: A narrative review"],"prefix":"10.14440","volume":"8","author":[{"given":"Pasquale","family":"Caponnetto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Polosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5574","published-online":{"date-parts":[[2020,10,5]]},"container-title":["Health Psychology Research"],"original-title":[],"link":[{"URL":"https:\/\/api.healthpr.org\/uploads\/file\/asp\/202504090814264f2553147.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.pagepressjournals.org\/index.php\/hpr\/article\/download\/9237\/9059","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.healthpr.org\/uploads\/file\/asp\/202504090814264f2553147.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T05:09:43Z","timestamp":1760418583000},"score":1,"resource":{"primary":{"URL":"https:\/\/healthpr.org\/journal\/HPR\/8\/2\/10.4081\/hpr.2020.9237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,5]]},"references-count":0,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,10,5]]}},"URL":"https:\/\/doi.org\/10.4081\/hpr.2020.9237","relation":{},"ISSN":["2420-8124"],"issn-type":[{"value":"2420-8124","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,5]]}}}